Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland

[1] Baumgart DC(2007)Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 1641-1657

[2] Sandborn WJ(2007)The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients Am J Gastroenterol 102 794-802

[3] Feagan BG(2010)The practice parameters committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee Am J Gastroenterol 105 501-523

[4] Reinisch W(2012)Ulcerative colitis Lancet 380 1606-1619

[5] Rutgeerts P(2002)Ulcerative colitis Lancet 359 331-340

[6] Kornbluth A(2012)Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 257-265

[7] Sachar DB(2014)Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis J Gastroenterol 49 283-294

[8] Ordás I(1995)Ileal pouch-anal anastomoses complications and function in 1005 patients Ann Surg 222 120-127

[9] Eckmann L(2005)Incidence and outcome of complications following restorative proctocolectomy Am J Surg 190 39-42

[10] Talamini M(2007)The epidemiology and healthcare resource use in patients with Crohn’s disease: a population based UK study Value Health 10 A355-1142

[1] Baumgart DC(2007)Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 1641-1657

[2] Sandborn WJ(2007)The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients Am J Gastroenterol 102 794-802

[3] Feagan BG(2010)The practice parameters committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee Am J Gastroenterol 105 501-523

[4] Reinisch W(2012)Ulcerative colitis Lancet 380 1606-1619

[5] Rutgeerts P(2002)Ulcerative colitis Lancet 359 331-340

[6] Kornbluth A(2012)Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 257-265

[7] Sachar DB(2014)Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis J Gastroenterol 49 283-294

[8] Ordás I(1995)Ileal pouch-anal anastomoses complications and function in 1005 patients Ann Surg 222 120-127

[9] Eckmann L(2005)Incidence and outcome of complications following restorative proctocolectomy Am J Surg 190 39-42

[10] Talamini M(2007)The epidemiology and healthcare resource use in patients with Crohn’s disease: a population based UK study Value Health 10 A355-1142